![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 05, 2019 12:12:35 AM
I agree. Dr. Duffy is no dummy. He has a stellar background and the right credentials. He could go anywhere. His move to NWBO is not primarily based upon personal belief. He did not go begging for a job at NWBO. They needed to do some "selling". People like Dr. Duffy don't make moves that are highly speculative. Of course, there is risk but it is highly calculated. I am sure that LP pulled back the covers. LP & co. know a hell of a lot more than most with all the data they have, consultants, SAB, PIs, professional statisticians, etc., etc. NWBO had to lay it out for Dr. Duffy rather than say "stay tuned" or "trust us". I am sure that Dr. Duffy asked a lot of questions and LP, Boynton, Bosch, et al gave him what he perceived as satisfactory answers, enough so that he was compelled to join. He has all the right credentials to do DD and ask all the right questions. And he got the answers we, the shareholders, would love to know. In a sense, if Dr. Duffy is convinced enough to join the little "engine that could", this is absolutely a huge vote of confidence for shareholders.
Dr. Duffy may be joining for collaborative trial projects involving both L and D, however, in order to be convinced to join, he had to be pretty well convinced on the DC VAX L prospects. Great hire and the beginning of good things to come. Maybe, just maybe, I am wrong about my negativity towards NWBO management. Not ashamed to eat crow with the salve of success for both patients and long suffering investors.
I, for one, could not be more pleased. Great move!
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM